Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis
Erin M Warshaw, Ross Jon Wohlhuter, An Liu, Sarah A. Zeller, Rachel A. Wenner, Sacharitha Bowers, Julie C. Schultz, H. Irving Katz, Calogera L. McCormick, Anne Parneix-Spake
Dive into the research topics of 'Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis'. Together they form a unique fingerprint.